Chemed (NYSE:CHE) Hits New 52-Week High – Time to Buy?

Chemed Corporation (NYSE:CHE)’s share price reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $551.74 and last traded at $544.6710, with a volume of 9304 shares. The stock had previously closed at $546.51.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on CHE. Royal Bank Of Canada increased their price target on Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Bank of America restated a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Oppenheimer increased their price objective on Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a report on Friday, July 31st. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Finally, Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $530.75.

Chemed Trading Down 0.5%

The company’s fifty day moving average price is $473.28 and its two-hundred day moving average price is $438.37. The company has a market cap of $7.11 billion, a price-to-earnings ratio of 27.26, a price-to-earnings-growth ratio of 2.04 and a beta of 0.51. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. During the same quarter in the previous year, the company posted $4.27 EPS. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Research analysts expect that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were given a dividend of $0.60 per share. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.4%. Chemed’s payout ratio is currently 12.05%.

Insiders Place Their Bets

In other news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Patrick P. Grace sold 190 shares of the business’s stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $532.00, for a total value of $101,080.00. Following the transaction, the director owned 3,533 shares of the company’s stock, valued at $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 3,537 shares of company stock valued at $1,782,654. Company insiders own 3.33% of the company’s stock.

Institutional Investors Weigh In On Chemed

Hedge funds have recently modified their holdings of the business. Legacy Wealth Asset Management LLC lifted its holdings in shares of Chemed by 25.8% during the 2nd quarter. Legacy Wealth Asset Management LLC now owns 3,056 shares of the company’s stock valued at $1,423,000 after purchasing an additional 626 shares in the last quarter. Sunburst Financial Group LLC increased its stake in Chemed by 12.0% during the 2nd quarter. Sunburst Financial Group LLC now owns 812 shares of the company’s stock worth $378,000 after purchasing an additional 87 shares in the last quarter. First Heartland Consultants Inc. raised its holdings in Chemed by 14.5% during the 2nd quarter. First Heartland Consultants Inc. now owns 1,404 shares of the company’s stock worth $654,000 after buying an additional 178 shares during the period. GAMMA Investing LLC raised its holdings in Chemed by 149.0% during the 2nd quarter. GAMMA Investing LLC now owns 620 shares of the company’s stock worth $289,000 after buying an additional 371 shares during the period. Finally, Somerset Trust Co bought a new position in Chemed in the second quarter valued at approximately $228,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.